Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODT, ESWL, and Combined Therapy for Radiolucent Renal Stones
NCT06814834Completed
- Sponsor
- Cairo University
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of potassium sodium hydrogen citrate in nephrolithiasis (3 arms), sponsored by Cairo University. Primary endpoint: Stone-free status at 3 months. Started Dec 2023; status: completed.
02
Drugs
potassium sodium hydrogen citrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT06814834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06814834.